Chloride channel-3 mediates multidrug resistance of cancer by upregulating P-glycoprotein expression

Area of Science:

• Molecular Biology
• Cancer Research
• Ion Channel Function

Background:

• Chloride channel-3 (ClC-3) is a voltage-gated chloride channel implicated in tumor cell chemoresistance.
• Multidrug resistance (MDR) remains a significant challenge in cancer chemotherapy, limiting treatment efficacy.
• Understanding novel mechanisms of MDR is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To elucidate a new mechanism by which ClC-3 mediates multidrug resistance (MDR) in cancer cells.
• To investigate the role of ClC-3 in P-glycoprotein (P-gp) expression and activation of the NF-κB signaling pathway.

Main Methods:

• Analysis of ClC-3 expression in drug-resistant cancer cell lines (A549/paclitaxel, MCF-7/doxorubicin) and their sensitive counterparts.
• Manipulation of ClC-3 expression in cancer cells to assess its impact on drug sensitivity and resistance.
• Utilized double transgenic MMTV-PyMT/CLCN3 mice with spontaneous mammary cancer to evaluate drug resistance in vivo.
• Investigated the effect of ClC-3 on MDR1 mRNA and P-gp expression, and its activation of the nuclear factor-κB (NF-κB) signaling pathway.

Main Results:

• ClC-3 was highly expressed in paclitaxel-resistant lung adenocarcinoma (A549) and doxorubicin-resistant breast carcinoma (MCF-7) cells.
• Altering ClC-3 expression modulated drug sensitivity in both sensitive and resistant cell lines, and in MMTV-PyMT/CLCN3 mice.
• ClC-3 upregulated MDR1 mRNA and P-gp expression by activating the NF-κB signaling pathway.

Conclusions:

• ClC-3 expression induces multidrug resistance (MDR) in cancer cells through a novel mechanism involving NF-κB signaling.
• Upregulation of NF-κB-dependent P-gp expression by ClC-3 contributes significantly to cancer drug resistance.
• Targeting ClC-3 may represent a potential therapeutic strategy to overcome MDR in various cancers.